NASDAQ · NOVTU

Novanta Inc.. Tangible Equity

$61.32 +$0.54 (+0.89%) 1D Market open
Session Pulse Regular session 1 mentions on Mon No new SEC filings since Mon close its sector ranked 9/11 this week Full pulse →

Key Metrics

$2.20B
Market cap
40.93×
P/E · TTM
$1.00B
Revenue · TTM
$53.72M
Net income
EPS · TTM $1.49
Dividend yield
Free cash flow $68.50M
Beta · 1Y 1.50
EBITDA · TTM $132.11M
Gross margin 44.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    A material event was filed (Form 8-K).

    8-K - NOVANTA INC (0001076930) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 7
    The stock moved -8.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 7
  • May 12
    The stock moved +11.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 12

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value$2.05B
Shares outstanding
52-wk range$47.57 – $75.07
Avg volume · 20D111.0K
Net cash $147.38M
Book value / share$36.29
IndustryMiscellaneous Electrical Machinery, Equipment & Supplies
ExchangeNASDAQ
About Novanta Inc.. Tangible Equity
IPO dateNov 12, 2025
Employees3000

Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E40.93
P/S2.19
P/FCF32.10
EV/EBITDA15.53
EV/Sales2.04
Graham №$34.84

Profitability

Gross 44.2%
Operating 6.9%
Net 5.3%
FCF 6.8%
ROE / ROIC 5.2% · 4.6%

Financial Health

Current ratio3.56
Quick ratio2.69
Debt / equity0.18
Debt / EBITDA 1.83
Net cash $147.38M
Working capital$566.01M

Cash Flow · TTM

Operating CF $83.98M
Capex −$15.48M
Free cash flow $68.50M
Buybacks $51.76M
Dividends paid
Shareholder yield 2.4%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

4.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$34.84 vs $60.86
Trades 1.7× above classic defensive value — priced for growth
Fundamentals through 2026-04-03 · computed by TickerWolf from SEC filings